Test Price
2,800 AED✅ Home Collection Available
RGS9BP Gene Bradyopsia Genetic Test in UAE | AED 2800 | 2026 DHA Guidelines
تحليل جين RGS9BP لبطء الرؤية بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO Accredited NGS processing, validated by DHA guidelines.
🚑 Premium Logistics:
Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
📞 Clinical Guidance:
Telephonic Post-Test Clinical Guidance for result interpretation by our medical team.
💳 Insurance Verification:
Direct Billing Verification via WhatsApp: +971 54 548 8731
ملخص تنفيذي: دقة تشخيصية بنسبة 99.9% مع خدمة سحب الدم المنزلي المعتمدة من الهيئة واستشارة طبية لاحقة.
Clinical Overview
The RGS9BP gene test uses Next Generation Sequencing (NGS) to identify pathogenic variants linked to bradyopsia, a rare cone dysfunction syndrome causing prolonged light adaptation and reduced dynamic visual acuity. يقوم الاختبار بتسلسل الجين RGS9BP للكشف عن الطفرات المسببة لبطء الرؤية الوراثي.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) – full gene coverage | Targeted panel / Sanger sequencing (partial) |
| Turnaround Time | 3‑4 weeks | 4‑8 weeks |
| Pre‑Test Genetic Counselling | Included (pedigree chart + informed consent) | Often extra cost |
| Sample Options | Whole Blood / Extracted DNA / One‑drop blood on FTA Card | Blood only (venipuncture) |
Physician Insight & Safety Protocol
“As an ophthalmology-focused genetic test, this analysis reveals the molecular basis of bradyopsia, strongly correlating with detailed electroretinography and dynamic visual function assessments. I urge every patient to discuss the results with their ophthalmologist and a genetic counsellor, never skipping clinical correlation. Early diagnosis enables tailored lifestyle adjustments and sports performance management.”
— Dr. PRABHAKAR REDDY (DHA License: 61713011), Senior Clinical Geneticist
⚠ Medication Warning
Do not discontinue any prescribed medication or alter your eye care regimen based on this test alone without consulting your treating physician.
🔴 Safety Exclusion Criteria & Emergency Red Flags
- Acute ocular pain, sudden vision loss, or severe photophobia – seek immediate emergency eye care.
- Pregnancy is not an exclusion, but genetic counselling must adapt to prenatal context; always inform your physician.
- Test is not validated for asymptomatic children under 12 years without a genetic counsellor’s approval as per UAE CDS Law 2026 (Minors).
- If you are taking blood-thinners, inform the home collection nurse to ensure safe phlebotomy.
- Positive result may require additional confirmatory testing (e.g., ERG, full-field sensitivity test) – do not self-interpret.
Patient FAQs & Clinical Guidance
1. What is the RGS9BP gene test and who should consider it?
The RGS9BP Genetic Test identifies disease-causing variants responsible for bradyopsia, providing definitive molecular diagnosis for patients with prolonged light adaptation and reduced dynamic visual acuity. It is recommended for individuals with suspected cone dysfunction, abnormal ERG findings, or a family history of bradyopsia. Ophthalmologists, sports scientists evaluating dynamic vision, and medical researchers investigating inherited retinal disorders can all benefit from this targeted analysis.
يقوم اختبار جين RGS9BP بتحديد الطفرات المسببة لبطء الرؤية الوراثي، ويُنصح به للأشخاص الذين يعانون من صعوبة التكيف مع الإضاءة أو لديهم تاريخ عائلي للمرض.
2. How is the test performed and what is the turnaround time?
The test requires a simple blood sample (whole blood, extracted DNA, or one drop on an FTA card) collected via our ISO-certified cold-chain home service, with results delivered in 3 to 4 weeks. After your sample reaches our DHA-licensed laboratory (License 9834453), NGS sequencing and bioinformatics analysis are completed under strict quality control. A pre-test genetic counselling session is mandatory to draw a pedigree chart and ensure informed consent.
يتم سحب العينة في المنزل (دم أو حمض نووي على بطاقة FTA)، وتظهر النتائج خلال 3 إلى 4 أسابيع بعد جلسة استشارة وراثية إلزامية.
3. What are the risks, and is genetic counselling necessary?
This non‑invasive genetic test carries no physical risk beyond standard phlebotomy; however, the psychological impact of a positive result requires mandatory pre‑ and post‑ genetic counselling. All patient data is protected under UAE PDPL and Federal Decree‑Law No. 41 of 2024 (Art. 87). We provide complimentary telephonic guidance with a DHA-credentialed counsellor, and insurance verification is available via WhatsApp at +971 54 548 8731.
المخاطر الجسدية منعدمة تقريباً، لكن النتائج قد تحمل أثراً نفسياً؛ لذا فإن الاستشارة الوراثية قبل وبعد الفحص إلزامية بموجب القوانين الإماراتية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians